Partnerships and M&A Shape the FutureDublin, April 04, 2025 (GLOBE NEWSWIRE) -- The "Cell Therapy Manufacturing Market Industry Trends and Global Forecasts to 2035, by Type of Cell Therapy, Source of ...

Merdad Parsey, the company's chief medical officer, was an "involuntary termination." Gilead Sciences Inc. CEO Daniel O'Day's compensation rose 4.8% last year to $23.7 million — roughly $97 for ...

Less than three years after being spun out of Oxford University, privately-held biotech MiroBio is heading for a takeover by Gilead Sciences in a $405 million deal. MiroBio was formed in 2019 to ...

Across the recent three months, 14 analysts have shared their insights on Gilead Sciences GILD, expressing a variety of opinions spanning from bullish to bearish. The following table encapsulates ...

Gilead CEO Daniel O’Day saw another rise in his pay in 2024, reflecting the steadily upward trajectory of the company since he took the reins in 2019. O’Day received a compensation package of ...

Have you been paying attention to shares of Gilead Sciences (GILD)? Shares have been on the move with the stock up 17.1% over the past month. The stock hit a new 52-week high of $117.39 in the ...

The Handmaid’s Tale Season 6 trailer dropped on Wednesday, promising a revolutionary conclusion to the story in Gilead. The series that has helped define TV for the last decade is coming to a ...